DuPont de Nemours Inc vs Nike Inc — how do they compare? DuPont de Nemours Inc trades at $130 (market cap $17.89B), while Nike Inc trades at $34.71 (market cap $51.60B). The key difference: Nike Inc is far larger — about 2.9× DuPont de Nemours Inc's market cap, and Nike Inc pays the higher dividend (4.72%). Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and Nike Inc for 155 Days on average.
| DD | NKE | |
|---|---|---|
Market Cap | $17.89B | $51.60B |
Volume | 816,409 | 43,506,062 |
Sector | Basic Materials | Consumer Cyclical |
52-Week High | $154.59 | $69.68 |
52-Week Low | $92.49 | $33.87 |
Typical Hold Time | 89 Days | 155 Days |
Enterprise Value | $19.28B | $54.30B |
Dividend Yield | 1.81% | 4.72% |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $132.48, up 1.07% with neutral technical signals. The company shows mixed fundamentals with strong recent earnings beats but declining revenue from $12.4B in 2024 to $6.85B in 2025, resulting in a net loss of $779M. Analyst consensus is bullish with 59% buy ratings, though the $95 consensus price target suggests downside risk. Recent developments include new product launches in sustainable materials and digital tools, alongside ongoing legal settlements related to PFAS contamination.
Outlook remains cautious due to revenue contraction and margin pressure, offset by innovation in high-growth sectors like healthcare and water technologies. Key risks include legal liabilities from PFAS lawsuits and volatile cash flows, while institutional sentiment appears divided with recent stake reductions by several funds.
Nike (NKE) trades at $34.74, up 1.11% with bearish technical signals despite recent earnings beats. The company faces revenue pressure with FY2025 sales declining to $46.31B and net margin compressing to 6.74%. Analyst consensus remains positive with a $36.98 price target, though technical indicators show 16 sell signals against 2 buy signals. Recent news highlights challenges in China and EMEA markets while emphasizing Nike's strong brand positioning.
Nike's investment case balances strong brand equity against near-term operational headwinds. The stock offers value at 16.62 P/E with 21.56% ROE, but investors face risks from sluggish consumer demand and margin pressure. The upcoming Q4 2026 earnings on June 30 will be critical for confirming turnaround progress.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →